Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors Use among Heart Failure Patients and the Role of Pharmacists in Early Initiation of Therapy

• Egile Nagusiak: Mohammed Aldhaeefi (Egilea), Brandon Beers (Egilea), Jenny Shah (Egilea), Saba Saeidi Rizi (Egilea), Dhakrit Rungkitwattanakul (Egilea), Oliver Nimoh (Egilea), Victoria Frimpong (Egilea), Jackie Gonzalez (Egilea), Sanaa Belrhiti (Egilea), Fatima Urooj (Egilea), Deborah Williams (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2023-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Heart failure (HF) is a growing major public health and economic concern in the United States and worldwide. Heart failure mortality rates can be as high as 75% despite advances in therapies. HF is expected to be the fastest growing among all cardiovascular diseases, with HF-associated direct medica...